IL1B and systemic lupus erythematosus: EET-A treatment to SLE mice reduced renal mRNA TNF-α expression 70%, IL-6 expression 74%), IL-1β expression 80% and IFN-γ expression 76% compared to vehicle treated SLE mice (Figure 2A–D).